Home / Inspections / 1182133

1182133

Apnar Pharma LLP — FEI 3011136472

Inspection Details

Classification: No Action Indicated (NAI) (NAI)
End Date: September 1, 2022
Fiscal Year: 2022
Product Type: Drugs
Project Area: Drug Quality Assurance
Location: East Windsor, NJ (United States)